β-Adrenergic modulation of myocardial conduction velocity: Connexins vs. sodium current

Annabel S Campbell1, Scott R Johnstone1, George S Baillie1

  • 1University of Glasgow, United Kingdom.

Insights

Autonomic nervous system influences heart function by altering electrical conduction. This review examines how beta-adrenergic receptor activation impacts ventricular action potential conduction velocity, a key factor in cardiac output.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Autonomic Nervous System

Background:

  • The heart's cardiac output is rapidly modulated by the autonomic nervous system, affecting heart rate and contractility.
  • While autonomic control of heart rate and contractility is well-studied, its influence on electrical propagation (conduction velocity) is less understood.
  • Conduction velocity (CV) of the action potential (AP) is crucial for efficient heart pumping and myocardial electrical stability.

Purpose of the Study:

  • To review the literature on the modulation of ventricular AP conduction velocity by beta-adrenergic receptor (β-AR) activation.
  • To highlight unresolved issues regarding the mechanisms and extent of β-AR-mediated changes in CV.

Main Methods:

  • Review of existing in vivo and in vitro studies on cardiac electrophysiology.
  • Analysis of research on cardiomyocyte electrophysiology and gap junction (GJ) function.
  • Examination of studies investigating sympathetic nervous system stimulation effects on ventricular CV.

Main Results:

  • Sympathetic stimulation shows variable effects on ventricular CV in whole-heart studies, complicated by increased heart rate.
  • Cellular studies indicate β-AR activation alters AP shape and amplitude, but its direct impact on CV remains unclear.
  • There is limited consensus on how β-AR activation alters GJ conductance and its contribution to CV changes.

Conclusions:

  • Understanding the precise mechanisms by which β-AR activation influences ventricular CV is critical.
  • Further research is needed to resolve discrepancies regarding GJ conductance modulation and its role in AP propagation.
  • Clarifying these mechanisms will enhance our understanding of cardiac electrical stability and pumping efficiency.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.7K
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
5.8K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.4K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.4K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
7.4K